HDAC1 and colorectal carcinoma: Together, these studies expand the fundamental knowledge urgently needed for how HDACi decreases HDAC1 lactylation and identify that the combination of HDACi and ferroptosis inducer (FIN) treatment may be an innovative and potent therapeutic strategy for CRC.